Patent Assignment
Reel/Frame 028921/0519
Notice of Change in Registered Office Address
Recorded: 2012-09-07
Pages: 2
Assignor
ALKERMES PHARMA IRELAND LIMITED
Executed: 2012-02-23
Assignee
ALKERMES PHARMA IRELAND LIMITED
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IRELAND
Covered Properties
(4)
Injectable Nanoparticulate Olanzapine Formulations
Nanoparticulate Corticosteroid and Antihistamine Formulations Methods of Making, and Methods of Administering Thereof
Injectable Nanoparticulate Olanzapine Formulations
Application:
12/333,233 →
Publication:
US 2009/0155331
Injectable Nanoparticulate Olanzapine Formulations
Application:
13/024,315 →
Publication:
US 2011/0195095
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Change of Address
Jul 5, 2011
From: ELAN PHARMA INTERNATIONAL LIMITED
To: ELAN PHARMA INTERNATIONAL LIMITED
Reel/Frame 026544/0598 →
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Notice of Change in Registered Office Address
Sep 7, 2012
From: EDT PHARMA HOLDINGS
To: EDT PHARMA HOLDINGS
Reel/Frame 028921/0475 →
Asset Transfer Agreement
Sep 7, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 028921/0442 →
Change of Name
Sep 7, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028923/0247 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Release of Patent Security Agreement (First Lien)
Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →
Security Interest
Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →
Release of Security Interest in Patents Previously Recorded at Reel/Frame (073213/0302)
Feb 13, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 074858/0429 →
Security Interest
Feb 13, 2026
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 074858/0405 →